BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
-13.72%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.5B
AUM Growth
+$2.5B
Cap. Flow
+$282M
Cap. Flow %
11.27%
Top 10 Hldgs %
45.64%
Holding
89
New
6
Increased
32
Reduced
5
Closed
8

Top Buys

1
ITOS
iTeos Therapeutics
ITOS
$45.1M
2
RLAY icon
Relay Therapeutics
RLAY
$41.9M
3
ACRS icon
Aclaris Therapeutics
ACRS
$39.3M
4
ARGX icon
argenx
ARGX
$31.5M
5
CINC
CinCor Pharma, Inc. Common Stock
CINC
$30.4M

Top Sells

1
AMRN
Amarin Corp
AMRN
$55.5M
2
XENE icon
Xenon Pharmaceuticals
XENE
$51.7M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$29.4M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
$6.95M
5
GLPG icon
Galapagos
GLPG
$6.83M

Sector Composition

1 Healthcare 99.31%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LXRX icon
26
Lexicon Pharmaceuticals
LXRX
$392M
$30M 1.2%
14,356,589
-3,411
-0% -$7.13K
ACIU icon
27
AC Immune
ACIU
$227M
$29.7M 1.19%
7,428,379
+366,000
+5% +$1.46M
STRO icon
28
Sutro Biopharma
STRO
$85.6M
$28.3M 1.13%
3,447,946
+2,522,798
+273% +$20.7M
VSTM icon
29
Verastem
VSTM
$585M
$28.2M 1.13%
19,974,658
+2,912,500
+17% +$4.11M
PNT
30
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$26.8M 1.07%
3,367,826
+447,300
+15% +$3.57M
TYRA icon
31
Tyra Biosciences
TYRA
$657M
$26.5M 1.06%
2,472,327
+598,995
+32% +$6.41M
ANTX icon
32
AN2 Therapeutics
ANTX
$35.3M
$24.4M 0.97%
+1,616,665
New +$24.4M
EPIX icon
33
ESSA Pharma
EPIX
$11.2M
$22.8M 0.91%
3,695,629
+844,168
+30% +$5.22M
OVID icon
34
Ovid Therapeutics
OVID
$94.6M
$21.5M 0.86%
6,851,051
+220,000
+3% +$691K
GBIO icon
35
Generation Bio
GBIO
$40.3M
$20.6M 0.82%
2,802,950
+2,613,900
+1,383% +$19.2M
IDYA icon
36
IDEAYA Biosciences
IDYA
$2.26B
$17.9M 0.72%
+1,600,559
New +$17.9M
RAIN
37
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$17.9M 0.72%
3,526,729
+568,922
+19% +$2.88M
VIRX
38
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$17.2M 0.69%
3,614,662
+175,718
+5% +$836K
JANX icon
39
Janux Therapeutics
JANX
$1.38B
$16.4M 0.66%
1,142,340
+125,026
+12% +$1.79M
PVLA
40
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$16.1M 0.65%
5,328,239
– –
CNTA
41
Centessa Pharmaceuticals
CNTA
$2.13B
$15.7M 0.63%
1,755,545
+1,301,000
+286% +$11.7M
REPL icon
42
Replimune Group
REPL
$460M
$15.7M 0.63%
926,529
– –
CTMX icon
43
CytomX Therapeutics
CTMX
$350M
$15.5M 0.62%
5,803,700
– –
IMA
44
ImageneBio, Inc. Common Stock
IMA
$153M
$15.3M 0.61%
2,501,571
+703,200
+39% +$4.29M
WHWK
45
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$14.9M 0.6%
879,085
-20,307
-2% -$345K
NGM
46
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$14.6M 0.58%
955,000
– –
CFRX
47
DELISTED
ContraFect Corporation
CFRX
$14.5M 0.58%
3,972,300
– –
ALPN
48
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$14.3M 0.57%
1,589,495
– –
MTEM
49
DELISTED
Molecular Templates, Inc.
MTEM
$14M 0.56%
4,046,735
+917,136
+29% +$3.16M
CALT
50
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$13.9M 0.56%
750,000
– –
1
2
3 4